These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 29184405)

  • 1. Absence of lung fibrosis after a single pulmonary delivery of lipid nanocapsules in rats.
    Hureaux J; Lacoeuille F; Lagarce F; Rousselet MC; Contini A; Saulnier P; Benoit JP; Urban T
    Int J Nanomedicine; 2017; 12():8159-8170. PubMed ID: 29184405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. α-bisabolol-loaded lipid-core nanocapsules reduce lipopolysaccharide-induced pulmonary inflammation in mice.
    D'Almeida APL; Pacheco de Oliveira MT; de Souza ÉT; de Sá Coutinho D; Ciambarella BT; Gomes CR; Terroso T; Guterres SS; Pohlmann AR; Silva PM; Martins MA; Bernardi A
    Int J Nanomedicine; 2017; 12():4479-4491. PubMed ID: 28684908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation and characterization of tetrandrine-phospholipid complex loaded lipid nanocapsules as potential oral carriers.
    Zhao YQ; Wang LP; Ma C; Zhao K; Liu Y; Feng NP
    Int J Nanomedicine; 2013; 8():4169-81. PubMed ID: 24204145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid nanocapsules: ready-to-use nanovectors for the aerosol delivery of paclitaxel.
    Hureaux J; Lagarce F; Gagnadoux F; Vecellio L; Clavreul A; Roger E; Kempf M; Racineux JL; Diot P; Benoit JP; Urban T
    Eur J Pharm Biopharm; 2009 Oct; 73(2):239-46. PubMed ID: 19560538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lung inflammation does not affect the clearance kinetics of lipid nanocapsules following pulmonary administration.
    Patel A; Woods A; Riffo-Vasquez Y; Babin-Morgan A; Jones MC; Jones S; Sunassee K; Clark S; T M de Rosales R; Page C; Spina D; Forbes B; Dailey LA
    J Control Release; 2016 Aug; 235():24-33. PubMed ID: 27180635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fate of paclitaxel lipid nanocapsules in intestinal mucus in view of their oral delivery.
    Groo AC; Saulnier P; Gimel JC; Gravier J; Ailhas C; Benoit JP; Lagarce F
    Int J Nanomedicine; 2013; 8():4291-302. PubMed ID: 24235827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toxicological study and efficacy of blank and paclitaxel-loaded lipid nanocapsules after i.v. administration in mice.
    Hureaux J; Lagarce F; Gagnadoux F; Rousselet MC; Moal V; Urban T; Benoit JP
    Pharm Res; 2010 Mar; 27(3):421-30. PubMed ID: 20054705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of cellular uptake and cytotoxicity of paclitaxel loaded lipid nanocapsules in breast cancer cells.
    Valsalakumari R; Yadava SK; Szwed M; Pandya AD; Mælandsmo GM; Torgersen ML; Iversen TG; Skotland T; Sandvig K; Giri J
    Int J Pharm; 2021 Mar; 597():120217. PubMed ID: 33486035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paclitaxel loaded PEG(5000)-DSPE micelles as pulmonary delivery platform: formulation characterization, tissue distribution, plasma pharmacokinetics, and toxicological evaluation.
    Gill KK; Nazzal S; Kaddoumi A
    Eur J Pharm Biopharm; 2011 Oct; 79(2):276-84. PubMed ID: 21575719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipid nanocapsules as a new delivery system in copepods: Toxicity studies and optical imaging.
    Stancheva S; Souissi A; Ibrahim A; Barras A; Spriet C; Souissi S; Boukherroub R
    Colloids Surf B Biointerfaces; 2015 Nov; 135():441-447. PubMed ID: 26280818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The adaptation of lipid nanocapsule formulations for blood administration in animals.
    Hureaux J; Lagarce F; Gagnadoux F; Clavreul A; Benoit JP; Urban T
    Int J Pharm; 2009 Sep; 379(2):266-9. PubMed ID: 19467305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipid nanocarriers improve paclitaxel transport throughout human intestinal epithelial cells by using vesicle-mediated transcytosis.
    Roger E; Lagarce F; Garcion E; Benoit JP
    J Control Release; 2009 Dec; 140(2):174-81. PubMed ID: 19699246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced anti-tumor efficacy of paclitaxel with PEGylated lipidic nanocapsules in presence of curcumin and poloxamer: In vitro and in vivo studies.
    Anwar M; Akhter S; Mallick N; Mohapatra S; Zafar S; Rizvi MMA; Ali A; Ahmad FJ
    Pharmacol Res; 2016 Nov; 113(Pt A):146-165. PubMed ID: 27546165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid nanocapsules functionalized with polyethyleneimine for plasmid DNA and drug co-delivery and cell imaging.
    Skandrani N; Barras A; Legrand D; Gharbi T; Boulahdour H; Boukherroub R
    Nanoscale; 2014 Jul; 6(13):7379-90. PubMed ID: 24871584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and in vitro evaluations of new decitabine nanocarriers for the treatment of acute myeloid leukemia.
    Briot T; Roger E; Lautram N; Verger A; Clavreul A; Lagarce F
    Int J Nanomedicine; 2017; 12():8427-8442. PubMed ID: 29200853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymeric versus lipid nanocapsules for miconazole nitrate enhanced topical delivery:
    Abdel-Rashid RS; Helal DA; Alaa-Eldin AA; Abdel-Monem R
    Drug Deliv; 2022 Dec; 29(1):294-304. PubMed ID: 35037528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Copper-Mediated Disulfiram-Loaded pH-Triggered PEG-Shedding TAT Peptide-Modified Lipid Nanocapsules for Use in Tumor Therapy.
    Zhang L; Tian B; Li Y; Lei T; Meng J; Yang L; Zhang Y; Chen F; Zhang H; Xu H; Zhang Y; Tang X
    ACS Appl Mater Interfaces; 2015 Nov; 7(45):25147-61. PubMed ID: 26501354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid nanocapsules for transdermal delivery of ropivacaine: in vitro and in vivo evaluation.
    Zhai Y; Yang X; Zhao L; Wang Z; Zhai G
    Int J Pharm; 2014 Aug; 471(1-2):103-11. PubMed ID: 24858383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distribution of lipid nanocapsules in different cochlear cell populations after round window membrane permeation.
    Zou J; Saulnier P; Perrier T; Zhang Y; Manninen T; Toppila E; Pyykkö I
    J Biomed Mater Res B Appl Biomater; 2008 Oct; 87(1):10-8. PubMed ID: 18437698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of 9L gliosarcoma in rats by ferrociphenol-loaded lipid nanocapsules based on a passive targeting strategy via the EPR effect.
    Huynh NT; Morille M; Bejaud J; Legras P; Vessieres A; Jaouen G; Benoit JP; Passirani C
    Pharm Res; 2011 Dec; 28(12):3189-98. PubMed ID: 21691892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.